olanzapine - medicine shortage information
Back to ALL shortages and discontinuations Back to CRITICAL shortages and discontinuations
If you are having difficulty obtaining a medicine that has been prescribed to you, talk to your doctor or pharmacist to discuss suitable options to continue your care.
More information about medicine shortages and how to access alternative medicines is available at the Medicine Shortages hub
Product details |
Supply Impact Dates |
Further Details |
APO-OLANZAPINE ODT olanzapine 20 mg orally disintegrating tablet blister pack AUST R: 158986Active ingredients:
olanzapine
Dosage form: Tablet, orally disintegrating
Sponsor: Arrotex Pharmaceuticals Pty Ltd
Phone: 1800 195 055
|
From 20 Dec 2024 to 28 Feb 2025
|
Shortage status: Current
Availability: Limited Availability
Reason: Manufacturing
Management action: Alternative generic products are available.
|
PRYZEX olanzapine 2.5 mg tablet blister pack AUST R: 335101Active ingredients:
olanzapine
Dosage form: Tablet, uncoated
Sponsor: Arrotex Pharmaceuticals Pty Ltd
Phone: 1800 195 055
|
From 17 Dec 2024 to 21 Feb 2025
|
Shortage status: Current
Availability: Unavailable
Reason: Manufacturing
Management action: Alternative generic products are available.
|
ZYPREXA IM olanzapine 10mg powder for injection vial AUST R: 76867Active ingredients:
olanzapine
Dosage form: Injection, powder for
Sponsor: Pharmaco Australia Ltd
Phone: 1800201564
|
From 13 Dec 2024 to 13 Jan 2025
|
Shortage status: Current
Availability: Limited Availability
Reason: Unexpected increase in consumer demand
Management action: The sponsor is closely controlling the supply and working to expedite the next shipment.
|
OLANZAPINE ODT GENERICHEALTH 10 olanzapine 10 mg orodispersible tablet blister pack AUST R: 177793Active ingredients:
olanzapine
Dosage form: Tablet, orally disintegrating
Sponsor: Torrent Australasia Pty Ltd
Phone: +61 3 9809 7900
|
Deletion from market:
31 Jul 2024
|
Shortage status: Discontinued
Availability: Unavailable
Reason: Commercial Changes / Commercial viability
Management action: Alternative generic products are available.
|